Advanz Pharma Corp. is a pharmaceutical company, which engages in owning and licensing a diversified portfolio of branded and generic prescription products. It operates through the following segments: Advanz Pharma International, Advanz Pharma North America, and Corporate. The Advanz Pharma International segment specializes in the acquisition, licensing, and development of off-patent prescription medicines. The Advanz Pharma North America segment consists of branded products and authorized generic contracts which are manufactured through an out-sourced production network and sold primarily through a third party distribution network. The Corporate segment represents the centralized costs including costs associated with the group's office. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in Mississauga, Canada.